ROI

Of the top 10 pharma companies worldwide, GlaxoSmithKline looked beyond its own pipeline for new drugs most often, signing 67 in-licensing agreements in just two years, according to a Datamonitor analysis.

In an age of accountability, where every dollar counts, Deborah Dick-Rath talks to industry insiders about how they can make a measurable difference in their marketing mix